Bryan Greenhouse is an Infectious Disease physician affiliated with San Francisco General Hospital. OpenAlex indexes 386 publications with 13,050 citations (h-index 66).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4150 Clement St
San Francisco, CA 941211545
Telephone
415-221-4810Registry record last updated 8 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
9 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Longitudinal evaluation of interactions between variable PfEMP1 virulence genes, the anti-PfEMP1 antibody repertoire, and outcomes of naturally occurring Plasmodium falciparum infections
University of California, San Francisco
FY2026$816,441R01AI196061 - Mentoring translational scientists in international infectious disease research
University of California, San Francisco
FY2026$197,626K24AI144048 - Data and analysis ecosystem for eukaryotic pathogen targeted sequencing
University of California, San Francisco
FY2025$957,169U01AI184646
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The Journal of Infectious Diseases
2021 - Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Science Translational Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Geoffrey Manley, MD, PhD
San Francisco General Hospital
Melvin Cheitlin, MD
San Francisco General Hospital
John Yue, MD
San Francisco General Hospital
Anne Luetkemeyer, MD
San Francisco General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”